DKSH
Phillip Wray is a seasoned executive with extensive experience in the healthcare and pharmaceutical sectors. Currently serving as Vice President of the Healthcare Business Unit at DKSH in Vietnam since February 2017, Phillip is responsible for business development, sales and marketing excellence, and market expansion initiatives. Previously, Phillip held the role of General Director and CEO at Euvipharm Pharmaceutical JSC, leading the company through its integration with Valeant Pharmaceuticals. With past positions at Abbott Vascular, i-Synergize Asia Pacific, PharmaLink, Guidant, Solvay Pharmaceuticals, and Astra Pharmaceuticals, Phillip has a proven track record in business strategy, operational management, and sales leadership across the Asia Pacific region. Phillip holds a Master’s degree in Marketing from Macquarie Graduate School of Management and a Bachelor of Science in Pharmacology and Microbiology from the University of Sydney.
This person is not in any teams
This person is not in any offices
DKSH
9 followers
DKSH Holding AG is a Switzerland-based company that provides market expansion services. The Company's business activities are divided into four business units: Consumer Goods, Healthcare, Performance Materials, and Technology. The Consumer Goods business unit focuses on fast moving consumer goods, food services, luxury and lifestyle products in Asia. The Healthcare business unit provides market expansion services for healthcare companies seeking to grow their business in Asia. The Performance Materials business unit offers instant access to raw materials around the world, serving the chemical, pharmaceutical, food, beverage and personal care industries. The Technology business unit offers its customers a range of technologies from European, American and Asian manufacturers with a focus on advanced machinery for industry and construction, analytical and scientific instruments, components and consumables. The Company is the parent company of DKSH Group and operates numerous subsidiaries.